Blackhawk Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Blackhawk Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40,870	Closed	-$2.62M	–	73
2020 Q1	$2.62M	Sell	40,870 -586	-1%	-$35.8K	2.34%	9
2019 Q4	$2.1M	Buy	41,456 +211	+0.5%	+$12.1K	2.09%	13
2019 Q3	$2.09M	Buy	41,245 +1,140	+3%	+$53.6K	1.96%	15
2019 Q2	$1.82M	Buy	40,105 +4,166	+12%	+$194K	1.74%	21
2019 Q1	$1.72M	Buy	+35,939	New	+$1.79M	1.77%	17
2018 Q4	–	Sell	-9,831	Closed	-$453K	–	71
2018 Q3	$453K	Buy	9,831 +8,152	+486%	+$484K	0.64%	41
2018 Q2	$93K	Buy	1,679 +449	+37%	+$24.3K	0.11%	122
2018 Q1	$78K	Sell	1,230 -405	-25%	-$26.1K	0.07%	149
2017 Q4	$100K	Buy	+1,635	New	+$102K	0.09%	121

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Blackhawk Capital Partners's BMY Position: Q2 2020 in Review

Blackhawk Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 40,870 shares — an estimated $2.62M sold.

Blackhawk Capital Partners first reported a position in BMY in Q4 2017 and held it in 9 quarters. The position peaked at $2.62M in Q1 2020. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Blackhawk Capital Partners reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Blackhawk Capital Partners sold 40,870 Bristol-Myers Squibb shares in Q2 2020, an estimated $2.62M.
Blackhawk Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 9 quarters.
Blackhawk Capital Partners's Bristol-Myers Squibb position peaked at $2.62M in Q1 2020.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Blackhawk Capital Partners's 13F filing for Q2 2020, filed 4 Aug 2020.